+86-28-82633987
EN
CN EN

Arglabin

BP3076
84692-91-1
98%
Phytounique
Arglabin has antiatherogenic effects, it may represent a new promising compound to treat inflammation and type 2 diabetes mellitus development, it can attenuate inflammation, protect pancreatic β-cells from apoptosis, and prevent Type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet. Arglabin shows promising antitumor activity against different tumor cell lines, Arglabin-DMA inhibits cell proliferation of a variety of tumor types with IC(90)s in the range of 0.85 to 5.0 microg/ml. Arglabin is an organic heterotetracyclic compound and guaianolide sesquiterpene lactone that is acrylic acid which is substituted at position 2 by a 4-hydroxy-3,8-dimethyl-1,3a,4,5,6,7-hexahydroazulen-5-yl group in which the double bond in the 7-membered ring has been epoxidised and in which the hydroxy group and the carboxy group have undergone formal condensation to give the corresponding gamma-lactone. It is found in Artemisia glabella.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3076-5mg 5mg $96.00
BP3076-10mg 10mg $170.00
BP3076-20mg 20mg $180.00
BP3076-100mg 100mg $890.00
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

Arglabin Related Products

Product drug property prediction parameters

  • 38.8300

  • 2.2242

  • 2.2242

  • .2879

  • 6.3154

  • 7.5739

  • High

  • 56.3561

  • 5.1791

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.9

  • Yes

  • No

  • Yes

  • Yes